Cargando…
Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Association for the Study of Intestinal Diseases
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430004/ https://www.ncbi.nlm.nih.gov/pubmed/28522942 http://dx.doi.org/10.5217/ir.2017.15.2.147 |
| _version_ | 1783236140068765696 |
|---|---|
| author | Im, Jong Pil |
| author_facet | Im, Jong Pil |
| author_sort | Im, Jong Pil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5430004 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Korean Association for the Study of Intestinal Diseases |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54300042017-05-18 Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease? Im, Jong Pil Intest Res Editorial Korean Association for the Study of Intestinal Diseases 2017-04 2017-04-27 /pmc/articles/PMC5430004/ /pubmed/28522942 http://dx.doi.org/10.5217/ir.2017.15.2.147 Text en © Copyright 2017. Korean Association for the Study of Intestinal Diseases. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Im, Jong Pil Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease? |
| title | Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease? |
| title_full | Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease? |
| title_fullStr | Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease? |
| title_full_unstemmed | Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease? |
| title_short | Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease? |
| title_sort | adalimumab or infliximab: which is better for perianal fistula in crohn's disease? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430004/ https://www.ncbi.nlm.nih.gov/pubmed/28522942 http://dx.doi.org/10.5217/ir.2017.15.2.147 |
| work_keys_str_mv | AT imjongpil adalimumaborinfliximabwhichisbetterforperianalfistulaincrohnsdisease |